are very volatile and what can or will happen should never be underestimated. If Zohydro sales are significant, the stock could skyrocket from $8 to $14 three months from now as the result of the next earnings report.
I have a feeling that the stock will trade in the $0.30's and then surge to $0.75. Like I said it is intuition and so some significant news must be pending to realize this.
This is 'Rest Period Day One' after a nice concerted run up. This rest will be very brief and followed by a strong move into the $0.30's and hover during this leg in the $0.33 to $0.35 range.
"A Case for ZGNX in the Teens"
January 10, 2014
If sales of Zohydro were to be significant and the company posts a profit per share in Q3 2014 or Q4 2014, your looking at a stock that will triple from the current price per share to $13 to $15 a share.
IMNSHO, In My Not So Humble Opinion
An arrangement to offer and sell the shares was made before the announcement was made that the shares were being offered. This means that the company gets cash that is needed to bring products to market which is very expensive to do. This is good for everyone involved who are pro company and what will follow is a $2.00 a share stock in the near term.
My guess from an article that I read is that doctors will be inclined to write prescriptions for Zohydro because they can avoid malpractice lawsuits by avoiding other pain medications that contain acetaminophen and cause liver damage, because now they have an option.
The price will be near the value that it is today for about a week and the January 14 closing date. Then it will begin to climb back to where it was yesterday. After that the stock will eventually hit a new 52 Week High in the $3's sometime later this year.